发明名称 Incontinence therapy
摘要 Techniques for managing urinary or fecal incontinence include delivering a first type of therapy to generate a first physiological response and, upon detecting a trigger event, delivering a second type of therapy to generate a second physiological response. The first type of therapy can be delivered on a substantially regular basis, while the second type of therapy is delivered as needed to provide an additional boost of therapy. The trigger event for activating the delivery of the second type of therapy may include input from a sensor that indicates a bladder condition, patient activity level or patient posture, or patient input. In some examples, the therapy is stimulation therapy.
申请公布号 US9433783(B2) 申请公布日期 2016.09.06
申请号 US201514880066 申请日期 2015.10.09
申请人 Medtronic, Inc. 发明人 Wei Xuan K.;Bonde Eric H.;Miesel Keith A.;Lent Mark S.;Molnar Gregory F.
分类号 A61N1/00;A61N1/36;A61N1/05;A61N1/372 主分类号 A61N1/00
代理机构 Shumaker & Sieffert, P.A. 代理人 Shumaker & Sieffert, P.A.
主权项 1. A medical system comprising: a therapy delivery module configured to generate and deliver a first electrical stimulation therapy to a patient to generate a first physiological effect and a second electrical stimulation therapy to the patient to generate a second physiological effect that is different than the first physiological effect; and a processor configured to: control the therapy delivery module to deliver the first electrical stimulation therapy chronically to the patient over a period of time; andcontrol, during the period of time, the therapy delivery module to deliver the second electrical stimulation therapy temporarily only in response to received input, wherein the first and second electrical stimulation therapies are configured to reduce a likelihood of at least one of urinary voiding events or fecal voiding events.
地址 Minneapolis MN US
您可能感兴趣的专利